138 related articles for article (PubMed ID: 34929673)
1. Impact of Semi-Annual Albendazole on Lymphatic Filariasis and Soil-Transmitted Helminth Infection: Parasitological Assessment after 14 Rounds of Community Treatment.
Pion SDS; Chesnais CB; Weil GJ; Louya F; Boussinesq M; Missamou F
Am J Trop Med Hyg; 2021 Dec; 106(2):729-731. PubMed ID: 34929673
[TBL] [Abstract][Full Text] [Related]
2. The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
Pion SDS; Chesnais CB; Awaca-Uvon NP; Vlaminck J; Abdou A; Kunyu-Shako B; Kuyangisa Simuna G; Tambwe JP; Weil GJ; Boussinesq M
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008322. PubMed ID: 32574160
[TBL] [Abstract][Full Text] [Related]
3. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.
Pion SD; Chesnais CB; Bopda J; Louya F; Fischer PU; Majewski AC; Weil GJ; Boussinesq M; Missamou F
Am J Trop Med Hyg; 2015 May; 92(5):959-66. PubMed ID: 25758650
[TBL] [Abstract][Full Text] [Related]
4. Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.
Pion SDS; Chesnais CB; Weil GJ; Fischer PU; Missamou F; Boussinesq M
Lancet Infect Dis; 2017 Jul; 17(7):763-769. PubMed ID: 28372977
[TBL] [Abstract][Full Text] [Related]
5. Impact of Annual versus Semiannual Mass Drug Administration with Ivermectin and Albendazole on Helminth Infections in Southeastern Liberia.
Eneanya OA; Gankpala L; Goss CW; Bolay FK; Weil GJ; Fischer PU
Am J Trop Med Hyg; 2021 Nov; 106(2):700-709. PubMed ID: 34814104
[TBL] [Abstract][Full Text] [Related]
6. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.
Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E
Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265
[TBL] [Abstract][Full Text] [Related]
8. A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections.
Campillo JT; Awaca-Uvon NP; Tambwe JP; Kuyangisa-Simuna G; Vlaminck J; Weil GJ; Boussinesq M; Chesnais CB; Pion SDS
Parasit Vectors; 2021 Jun; 14(1):310. PubMed ID: 34103096
[TBL] [Abstract][Full Text] [Related]
9. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
Chami GF; Kabatereine NB; Tukahebwa EM
BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
11. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
Eneanya OA; Gankpala L; Goss CW; Momolu AT; Nyan ES; Gray EB; Fischer K; Curtis K; Bolay FK; Weil GJ; Fischer PU
Acta Trop; 2022 Jul; 231():106437. PubMed ID: 35405102
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
13. Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.
Campillo JT; Awaca-Uvon NP; Missamou F; Tambwe JP; Kuyangisa-Simuna G; Weil GJ; Louya F; Boussinesq M; Pion SDS; Chesnais CB
Clin Infect Dis; 2021 Jul; 73(1):e176-e183. PubMed ID: 32856050
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.
Supali T; Djuardi Y; Lomiga A; Nur Linda S; Iskandar E; Goss CW; Miller JP; Weil GJ; Fischer PU
Am J Trop Med Hyg; 2019 Feb; 100(2):336-343. PubMed ID: 30560772
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
[TBL] [Abstract][Full Text] [Related]
18. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
[TBL] [Abstract][Full Text] [Related]
19. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
[TBL] [Abstract][Full Text] [Related]
20. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
